These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 21844496

  • 1. Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus.
    Piha-Paul SA, Cohen PR, Kurzrock R.
    J Clin Oncol; 2011 Sep 10; 29(26):e727-30. PubMed ID: 21844496
    [No Abstract] [Full Text] [Related]

  • 2. How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?
    Locati LD, Bossi P, Licitra L.
    J Clin Oncol; 2012 Feb 20; 30(6):672; author reply 672-673. PubMed ID: 22253461
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitors.
    Bukowski RM.
    Clin Genitourin Cancer; 2007 Sep 20; 5(6):359-61. PubMed ID: 17956708
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temsirolimus for metastatic desmoplastic small round cell tumor.
    Thijs AM, van der Graaf WT, van Herpen CM.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1431-2. PubMed ID: 20730888
    [Abstract] [Full Text] [Related]

  • 10. [Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor].
    Mounier N, Vignot S, Spano JP.
    Bull Cancer; 2006 Nov 15; 93(11):1139-43. PubMed ID: 17145584
    [Abstract] [Full Text] [Related]

  • 11. Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors.
    Jedlickova Z, Burlakova I, Bug G, Baurmann H, Schwerdtfeger R, Schleuning M.
    Biol Blood Marrow Transplant; 2011 May 15; 17(5):657-63. PubMed ID: 20696263
    [Abstract] [Full Text] [Related]

  • 12. [Antihormonal therapy in breast cancer and mTOR inhibitors].
    Heudel PÉ, Tredan O, Ray-Coquard I, Treilleux I, Guastalla JP, Bachelot T.
    Bull Cancer; 2011 Dec 15; 98(12):1431-7. PubMed ID: 22133994
    [Abstract] [Full Text] [Related]

  • 13. Impact of mammalian target of rapamycin inhibition on autosomal-dominant polycystic kidney disease.
    Wüthrich RP, Kistler AD, Serra AL.
    Transplant Proc; 2010 Nov 15; 42(9 Suppl):S44-6. PubMed ID: 21095452
    [Abstract] [Full Text] [Related]

  • 14. Temsirolimus, the mTOR inhibitor, induces autophagy in adenoid cystic carcinoma: in vitro and in vivo.
    Liu W, Huang S, Chen Z, Wang H, Wu H, Zhang D.
    Pathol Res Pract; 2014 Nov 15; 210(11):764-9. PubMed ID: 24767255
    [Abstract] [Full Text] [Related]

  • 15. Temsirolimus.
    Stock C, Zaccagnini M, Schulze M, Teber D, Rassweiler JJ.
    Recent Results Cancer Res; 2010 Nov 15; 184():189-97. PubMed ID: 20072839
    [Abstract] [Full Text] [Related]

  • 16. Temsirolimus (Torisel) for advanced renal cell carcinoma.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):103-4. PubMed ID: 18084154
    [No Abstract] [Full Text] [Related]

  • 17. Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience.
    Errasti P, Izquierdo D, Martín P, Errasti M, Slon F, Romero A, Lavilla FJ.
    Transplant Proc; 2010 Oct 17; 42(8):3053-4. PubMed ID: 20970608
    [Abstract] [Full Text] [Related]

  • 18. Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment.
    García-Echeverría C.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4308-12. PubMed ID: 20561789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
    Hess G, Herbrecht R, Romaguera J, Verhoef G, Crump M, Gisselbrecht C, Laurell A, Offner F, Strahs A, Berkenblit A, Hanushevsky O, Clancy J, Hewes B, Moore L, Coiffier B.
    J Clin Oncol; 2009 Aug 10; 27(23):3822-9. PubMed ID: 19581539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.